Valiant Capital Partners has made a big bet on Eli Lilly.The drug giant is currently the largest long equity position of the Tiger Grandcub, accounting for 8.66 percent of the firm’s capital, according to the third-quarter letter, which was obtained by Institutional Investor.In the letter,